Real-Life Multicenter Study on Rare Epileptic Syndromes in Children and Adolescents to Track Seizure Control and Cognitive Outcomes

What this Trial Is About

Rare epilepsies make up about 20-30% of all epilepsy cases, but little is known about factors that can predict how patients will do over time. This lack of information makes it hard to give families clear guidance when a diagnosis is made and during ongoing care. Because few treatments exist, and reliable data are scarce, especially for rare forms like infantile spasm syndrome, Dravet syndrome, and Lennox-Gastaut syndrome, treatment recommendations are limited and vary between centers. This study is a real-life, observational follow-up of children and adolescents with rare epileptic syndromes. It aims to evaluate how patients respond to various treatments and to monitor changes in cognitive and psychiatric symptoms. The study takes advantage of the different treatment approaches used across centers, allowing comparison of seizure control and medium-term outcomes without assigning specific treatments. Participants will be followed for up to five years to assess the rate of seizure reduction over time. Researchers will collect data on seizure frequency, cognitive and psychiatric developments, and treatment responses during routine care visits. This long-term monitoring will help improve understanding of rare epilepsies and their management in everyday clinical settings.

Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents